Precisis accelerates international expansion: Steven Griffiths named Vice President European Sales

Heidelberg-based medical technology company Precisis, a specialist in neuromodulation, is strengthening its leadership team: Steven Griffiths has been appointed Vice President European Sales.

With more than 20 years of experience in the medtech industry, Griffiths brings deep expertise in sales leadership, market development, and international scaling. He most recently served as Director DACHL at Nevro. Prior to that, he held senior positions at Alcon and ALK, where he successfully built and managed sales structures.

In his new role, Griffiths will lead Precisis’ European sales strategy, solidify the company’s strong market position in the UK, and spearhead expansion into key strategic regions such as Spain, the Nordic countries, and the United Arab Emirates.

This appointment comes at a time of significant growth in the European medtech sector. Germany accounts for 25% of the market volume, with 68% of revenue generated through exports. Griffiths brings the international perspective and operational experience needed to help Precisis scale effectively across Europe.

The company’s core product, EASEE® – a minimally invasive brain pacemaker for the treatment of focal epilepsy – has received multiple awards for its patient-centric design and technological innovation. With nearly 60% of Europe’s population affected by neurological disorders, the demand for advanced therapy solutions continues to rise.

“Steven Griffiths combines strategic vision with hands-on leadership like few others,” says Karl Stoklosa, CEO of Precisis. “His leadership will be instrumental in scaling our impact and making EASEE® accessible to even more patients across Europe and beyond.”